- Agonization of GLP-1 in cardiology2020 | Faculty of Medicine in Pilsen
- Lixisenatide - a novel prandial GLP-1 receptor agonist2013 | Second Faculty of Medicine
- From gliptines to GLP-1 analogues2012 | Faculty of Medicine in Hradec Králové
- Individualization of therapy for type 2 diabetes: GLP-1 agonists2015 | First Faculty of Medicine
- Cardiovascular effects of GLP-1 receptor agonist treatment: focus on liraglutide2015 | First Faculty of Medicine
- Liraglutid; analog GLP-12011 | Second Faculty of Medicine
- Cardioascular effect of incretin-based therapies: comparison od DPP-4 inhibitors and GLP-1 agonists2014 | First Faculty of Medicine
- Treatment of type 2 diabetes mellitus by GLP-1 agonists2011 | First Faculty of Medicine
- GLP-1 analogues in therapy of obese adolescents. Early real-life experience with liraglutide treatment2023 | Second Faculty of Medicine
- Physiological secretion of GLP-1 (glucagon-like peptide-1)2015 | Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
- The effect of GLP‑1 receptor agonists on improving glucose control and decreasing body weight: results of direct comparative trials and network meta‑analysis2022 | First Faculty of Medicine
- Knowledge about GLP-1 based therapies changed the possibilities of diabetes treatment, but its use could be much broader2011 | Third Faculty of Medicine
- Effects of GLP-1 (glucagon-like peptide-1) on liver2013 | Third Faculty of Medicine
- Albiglutide - a GLP-1 agonist with a prolonged action2017 | First Faculty of Medicine, Third Faculty of Medicine
- Inkretiny (GIP a GLP-1) – aktuální pohled na patofyziologii a klinické perspektivy2022 | First Faculty of Medicine
- Clinical use of lixisenatide2014 | Second Faculty of Medicine
- Near future of oral antidiabetics2011 | Second Faculty of Medicine
- Incretin treatment of diabetes2011 | Second Faculty of Medicine
- Racionální a účinná kombinace agonisty GLP-1 receptoru a bazálního inzulinu2021 | First Faculty of Medicine
- Semaglutide: an effective antidiabetic agent with proven cardiovascular benefit in clinical practice2020 | First Faculty of Medicine
- Fixed combination of long-acting insulin with GLP-1 analogue as an option of treatment intensification in patients with type 2 diabetes mellitus2016 | First Faculty of Medicine
- Modern treatment of diabetes in questions and responses2014 | First Faculty of Medicine
- The Effect of GLP-1 Receptor Agonists on Postprandial Lipaemia2022 | First Faculty of Medicine
- Semaglutide in the treatment of type 2 diabetes mellitus2019 | First Faculty of Medicine
- Incretin hormones2011 | Faculty of Medicine in Hradec Králové
- Benefits of GLP-1 receptor agonists therapy for patients with cardiovascular disease2022 | First Faculty of Medicine
- Effect of the use of lixisenatide in antidiabetic therapy intensification2015 | First Faculty of Medicine
- Practical view of insulin therapy intensification with fixed combination injection therapy of liraglutide and degludec2017 | First Faculty of Medicine
- Glucagon-like peptide-1 and its significance in current diabetology2011 | First Faculty of Medicine
- Is the pharmacotherapy necessary for overweight and obese patients2008 | First Faculty of Medicine